Your browser doesn't support javascript.
loading
Restoration of miR-424 suppresses BCR-ABL activity and sensitizes CML cells to imatinib treatment.
Hershkovitz-Rokah, Oshrat; Modai, Shira; Pasmanik-Chor, Metsada; Toren, Amos; Shomron, Noam; Raanani, Pia; Shpilberg, Ofer; Granot, Galit.
Afiliação
  • Hershkovitz-Rokah O; Felsenstein Medical Research Center, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Israel.
  • Modai S; Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Israel.
  • Pasmanik-Chor M; Bioinformatics Unit, Faculty of Life Sciences, Tel Aviv University, Israel.
  • Toren A; Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Tel-Hashomer, Israel.
  • Shomron N; Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Israel.
  • Raanani P; Felsenstein Medical Research Center, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Israel; Institute of Hematology, Davidoff Cancer Center, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Israel.
  • Shpilberg O; Institute of Hematology, Assuta Medical Center, Tel-Aviv, Israel.
  • Granot G; Felsenstein Medical Research Center, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Israel. Electronic address: galitg@clalit.org.il.
Cancer Lett ; 360(2): 245-56, 2015 May 01.
Article em En | MEDLINE | ID: mdl-25697481
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Benzamidas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas de Fusão bcr-abl / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperazinas / Pirimidinas / Benzamidas / Leucemia Mielogênica Crônica BCR-ABL Positiva / Proteínas de Fusão bcr-abl / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article